Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 6 Gastrointestinal 4 Thoracic 2 Other hematologic neoplasm 2 NET 2 Lymphoid 2 Genitourinary 2 Endocrine 2 Breast 2 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 157 Nivolumab 132 Ipilimumab 77 Cyclophosphamide 46 Specimen Handling 44 Magnetic Resonance Spectroscopy 39 cemiplimab 35 Biopsy 31 fludarabine 28 trametinib 24 relatlimab 24 binimetinib 23 Interleukin-2 21 fludarabine phosphate 20 dabrafenib 20 atezolizumab 20 Radiotherapy 20 Opdualag 19 Radiosurgery 18 CTLA-4 Antigen 18 encorafenib 17 aldesleukin 17 Blood Specimen Collection 17 avelumab 14 Immunoglobulin G 14 Disulfides 13 lenvatinib 11 Bevacizumab 11 lifileucel 10 Paclitaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Data Collection × Dermatologic × 1 year × Clear all

NCT06432660 2026-02-06

PROMPT

Duke University

Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡